Zoetis Inc. (NYSE: ZTS) today announced the commercial launch of Portela ® (relfovetmab) in Canada and the European Union (EU) member states. Portela is the first long-acting anti-nerve growth factor ...

When Sanofi won FDA approval in July 2026 for the first anticancer treatment administered with an on-body injector (OBI), the Enable Injections enFuse platform made it possible. The enFuse OBI secured ...

A new under‑the‑skin version of isatuximab is now approved, giving multiple myeloma patients a much faster and more ...

According to Carney, who was present for his birth, Tornado was the biggest puppy of the litter and has lived up to his name ...

Up to 40% of dogs may have radiographic osteoarthritis New long-acting monoclonal antibody therapy offers three months of osteoarthritis pain relief for dogs with a single injection Zoetis Inc.

(NYSE: ZTS) today announced that it has recently launched Lenivia ® (izenivetmab injection) in Canada and the Europea ...

The FDA has approved a subcutaneous version of isatuximab (Sarclisa Escena, Sanofi-Aventis) for several multiple myeloma (MM) ...

FDA clears subcutaneous Sarclisa Escena for multiple myeloma, showing comparable overall response rates to IV delivery.

This video breaks down SubQ, a new LLM architecture claiming massive efficiency gains through subquadratic sparse attention. It explains how SubQ could handle up to 12 million tokens, reduce compute ...

Sumitomo Pharma Co., Ltd announced that Novo Nordisk Pharma Ltd has received a partial change approval of the manufacturing and marketing authorization from the Ministry of Health, Labour and Welfare ...

The Harnett County Animal Services Animal shelter was fined nearly $20,000 after veterinarians were accused of using inhumane euthanasia techniques. The fine comes after county officials said staff ...

A little-known Miami-based startup called Subquadratic emerged from stealth on Tuesday with a sweeping claim: that it has built the first large language model to fully escape the mathematical ...